Position in NAGE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$527,757
+$479,587 QoQ
Shares Held
119,673
+2217.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quantbot Technologies LP holds $15,790,416 across 98 Biotechnology names. NAGE ranks #9 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
47,043 | $2,480,106 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
81,651 | $2,287,044 | |
| 3 | RPRX |
Royalty Pharma plc
|
28,687 | $1,376,115 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
13,521 | $948,498 | |
| 5 | INVA |
Innoviva, Inc.
|
39,407 | $918,183 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
6,367 | $619,190 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
72,397 | $613,202 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,958 | $561,666 |
All Filings in NAGE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $527,757 | 119,673 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $48,170 | 5,163 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,099,468 | 76,299 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $185,858 | 26,936 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $155,843 | 29,349 | Shares | Sole | 2025-02-11 | |
| 2021-12-31 | $6,732 | 1,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,389 | 700 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $9,396 | 953 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $15,971 | 1,710 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||